PT J
AU Piko, B
   Bassam, A
   Dimak, S
   Kis, A
   Csiffari, M
   Rus-Gal, P
   Szabo, Zs
   Vereb, B
AF Piko, Bela
   Bassam, Ali
   Dimak, Sandor
   Kis, Anita
   Csiffari, Margit
   Rus-Gal, Paul
   Szabo, Zsolt
   Vereb, Blanka
TI Thoughts about thromboembolic events prophylaxis in cancer patients
SO MAGYAR ONKOLOGIA
LA Hungarian
DT Review
DE daganatos betegseg; venas tromboembolias esemeny; kockazati tenyezok; profilaxis; alacsony molekulatomegu heparin
ID daganatos betegseg; venas tromboembolias esemeny; kockazati tenyezok; profilaxis; alacsony molekulatomegu heparin
AB The risk of venous thromboembolic events (VTE) in cancer patients is higher than in the general population. Treatment may also increase this risk in these patients. Based on the appropriate criteria (of which the most important are the current ministerial guidelines) thrombosis prophylaxis should be started (given that there is no contraindication) on these patients and be continued while they are at risk. In the event of permanent risk thrombosis prophylaxis should be given lifelong. The drug of choice is low-molecular-weight heparin (LMWH) which is safer and more effective than the oral vitamin K antagonists. Platelet aggregation inhibitors have proved unsuccessful in this patient group. The evidence so far suggests that LMWH (during VTE prophylaxis) can have a positive impact on the course of cancer and perhaps it will be registered under the indication section for cancer patients in the future.
C1 [Piko, Bela] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
   [Bassam, Ali] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
   [Dimak, Sandor] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
   [Kis, Anita] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
   [Csiffari, Margit] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
   [Rus-Gal, Paul] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
   [Szabo, Zsolt] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
   [Vereb, Blanka] Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, Semmelweis u. 1., 5700 Gyula, Hungary.
RP Piko, B (reprint author), Bekes Megyei Kepviselotestulet Pandy Kalman Korhaza, Klinikai Onkologiai es Sugartherapias Osztaly, 5700 Gyula, Hungary.
EM dr.piko.bela@gmail.com
NR 3
PU Hungarian Cancer Society
PI Budapest
PA 7-9 Rath Gyorgy, Budapest H-1122, Hungary
SN 0025-0244
J9 MagyOnkol
JI Magy Onkol
PD SEP
PY 2011
VL 55
IS 3
BP 164
EP 169
PG 6
ER

EF